Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

imax corp. - IMAX

IMAX

Close Chg Chg %
25.75 -1.43 -5.55%

Closed Market

24.32

-1.43 (5.55%)

Volume: 1.39M

Last Updated:

Apr 4, 2025, 3:59 PM EDT

Trade Now

Company Overview: imax corp. - IMAX

IMAX Key Data

Open

$25.12

 Day Range

24.03 - 25.43

52 Week Range

14.96 - 27.70

 Market Cap

$1.36B

Shares Outstanding

53.02M

 Public Float

42.19M

Beta

0.91

 Rev. Per Employee

N/A

P/E Ratio

53.18

 EPS

$0.49

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

784.22K

  

IMAX Performance

1 Week
 
 -6.96%
 
1 Month
 
 -3.72%
 
3 Months
 
 -3.22%
 
1 Year
 
 50.59%
 
5 Years
 
 160.66%
 

IMAX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About imax corp. - IMAX

IMAX Corp. is an entertainment technology company, which engages in the business of motion picture technologies and presentations. It operates through the Content Solutions and Technology Products and Services segments. The Content Solutions segment includes content enhancement and distribution services. The Technology Products and Services segment focuses on the sale, lease, and maintenance of IMAX Systems. The company was founded by Graeme Ferguson, Roman Kroitor, Robert P. Kerr and William Shaw in 1967 and is headquartered in Mississauga, Canada.

IMAX At a Glance

IMAX Corp.
2525 Speakman Drive
Mississauga, Ontario L5K 1B1
Phone 1-905-403-6500 Revenue 352.21M
Industry Electronics/Appliances Net Income 26.06M
Sector Consumer Durables Employees 700
Fiscal Year-end 12 / 2025
View SEC Filings

IMAX Valuation

P/E Current 53.183
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 52.914
Price to Sales Ratio 3.915
Price to Book Ratio 4.526
Price to Cash Flow Ratio 19.466
Enterprise Value to EBITDA 13.82
Enterprise Value to Sales 4.643
Total Debt to Enterprise Value 0.17

IMAX Efficiency

Revenue/Employee 503,154.286
Income Per Employee 37,227.143
Receivables Turnover 2.556
Total Asset Turnover 0.428

IMAX Liquidity

Current Ratio 1.416
Quick Ratio 1.253
Cash Ratio 0.501

IMAX Profitability

Gross Margin 52.793
Operating Margin 14.996
Pretax Margin 10.703
Net Margin 7.399
Return on Assets 3.168
Return on Equity 9.102
Return on Total Capital 4.512
Return on Invested Capital 4.961

IMAX Capital Structure

Total Debt to Total Equity 92.871
Total Debt to Total Capital 48.152
Total Debt to Total Assets 33.492
Long-Term Debt to Equity 79.772
Long-Term Debt to Total Capital 41.36
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Imax Corp. - IMAX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
254.88M 300.81M 374.84M 352.21M
Sales Growth
+86.04% +18.02% +24.61% -6.04%
Cost of Goods Sold (COGS) incl D&A
124.95M 150.18M 166.08M 166.27M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
56.08M 56.66M 60.02M 65.50M
Depreciation
31.80M 31.92M 31.98M 31.52M
Amortization of Intangibles
6.08M 6.10M 5.95M 6.97M
COGS Growth
+4.95% +20.19% +10.59% +0.11%
Gross Income
129.93M 150.63M 208.76M 185.94M
Gross Income Growth
+624.00% +15.93% +38.60% -10.93%
Gross Profit Margin
+50.98% +50.07% +55.69% +52.79%
2021 2022 2023 2024 5-year trend
SG&A Expense
123.32M 146.19M 152.88M 133.12M
Research & Development
6.94M 3.40M 8.31M 3.20M
Other SG&A
116.38M 142.79M 144.57M 129.92M
SGA Growth
-7.23% +18.55% +4.58% -12.92%
Other Operating Expense
- - - -
-
Unusual Expense
(6.71M) 5.40M 3.43M 7.02M
EBIT after Unusual Expense
13.32M (968.00K) 52.45M 45.80M
Non Operating Income/Expense
4.76M (2.92M) 483.00K (14.00K)
Non-Operating Interest Income
2.22M 1.43M 2.49M 2.18M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
7.09M 5.88M 6.82M 8.08M
Interest Expense Growth
+1.17% -17.13% +16.06% +18.52%
Gross Interest Expense
7.09M 5.88M 6.82M 8.08M
Interest Capitalized
- - - -
-
Pretax Income
10.99M (9.77M) 46.12M 37.70M
Pretax Income Growth
+108.51% -188.91% +572.07% -18.26%
Pretax Margin
+4.31% -3.25% +12.30% +10.70%
Income Tax
20.56M 10.11M 13.05M 5.00M
Income Tax - Current - Domestic
915.00K 1.15M 3.10M 1.35M
Income Tax - Current - Foreign
16.65M 11.03M 11.40M 9.28M
Income Tax - Deferred - Domestic
231.00K (943.00K) (2.46M) 3.39M
Income Tax - Deferred - Foreign
2.77M (1.13M) 1.01M (9.02M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(9.58M) (19.88M) 33.07M 32.70M
Minority Interest Expense
12.75M 2.92M 7.73M 6.64M
Net Income
(22.33M) (22.80M) 25.34M 26.06M
Net Income Growth
+84.47% -2.11% +211.12% +2.86%
Net Margin Growth
-8.76% -7.58% +6.76% +7.40%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(22.33M) (22.80M) 25.34M 26.06M
Preferred Dividends
- - - -
-
Net Income Available to Common
(22.33M) (22.80M) 25.34M 26.06M
EPS (Basic)
-0.3776 -0.4023 0.4665 0.4949
EPS (Basic) Growth
+84.44% -6.54% +215.96% +6.09%
Basic Shares Outstanding
59.13M 56.67M 54.31M 52.65M
EPS (Diluted)
-0.3776 -0.4023 0.4594 0.4838
EPS (Diluted) Growth
+84.44% -6.54% +214.19% +5.31%
Diluted Shares Outstanding
59.13M 56.67M 55.15M 53.86M
EBITDA
62.69M 61.09M 115.90M 118.32M
EBITDA Growth
+200.65% -2.55% +89.71% +2.09%
EBITDA Margin
+24.60% +20.31% +30.92% +33.59%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 29.70
Number of Ratings 11 Current Quarters Estimate 0.202
FY Report Date 06 / 2025 Current Year's Estimate 1.197
Last Quarter’s Earnings 0.16 Median PE on CY Estimate N/A
Year Ago Earnings 0.95 Next Fiscal Year Estimate 1.352
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 9 9
Mean Estimate 0.20 0.30 1.20 1.35
High Estimates 0.29 0.37 1.40 1.62
Low Estimate 0.04 0.20 0.74 0.98
Coefficient of Variance 37.24 18.60 18.14 15.24

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 9 8
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Imax Corp. - IMAX

Date Name Shares Transaction Value
Mar 12, 2025 Mark Welton President IMAX Global Theatres 123,274 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 29,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 28,650 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 12,959 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 153,323 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.26 per share 3,872,938.98
Mar 12, 2025 Mark Welton President IMAX Global Theatres 180,713 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 167,214 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 129,549 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.26 per share 3,272,407.74
Mar 12, 2025 Mark Welton President IMAX Global Theatres 150,556 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Mark Welton President IMAX Global Theatres 136,231 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Anne Globe Chief Marketing Officer 16,500 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Robert Darin Lister Chief Legal & Sr Exec VP 150,848 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Anne Globe Chief Marketing Officer 24,452 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Anne Globe Chief Marketing Officer 12,225 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Anne Globe Chief Marketing Officer 7,753 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.26 per share 195,840.78
Mar 12, 2025 Robert Darin Lister Chief Legal & Sr Exec VP 163,805 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Richard Lewis Gelfond Chief Executive Officer; Director 704,599 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.26 per share 17,798,170.74
Mar 12, 2025 Richard Lewis Gelfond Chief Executive Officer; Director 829,676 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Richard Lewis Gelfond Chief Executive Officer; Director 765,354 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Imax Corp. in the News